Literature DB >> 18201639

Use of smoking-cessation treatments in the United States.

Saul Shiffman1, Sarah E Brockwell, Janine L Pillitteri, Joseph G Gitchell.   

Abstract

BACKGROUND: Health promotion efforts encourage smokers to quit and to use effective cessation treatments. Randomized controlled trials demonstrate that medications and behavioral treatments improve cessation rates, but retrospective surveys have been inconsistent. This study assessed frequency of quit attempts, use of treatments for cessation, and abstinence rates among treatment users and non-users.
METHODS: Data were analyzed from the 2003 Tobacco Use Special Cessation Supplement to the Current Population Survey. Participants included 29,537 U.S. smokers aged > or =18 years who smoked daily 12 months before the survey. Outcome measures included past-year quit attempts; use of behavioral, pharmacologic, and alternative treatments; receipt of social support; and abstinence for > or =4 weeks at time of survey.
RESULTS: Approximately 43.5% of smokers reported a quit attempt in the preceding year: 64.2% of attempters used no cessation treatments; 8.8% used behavioral treatment; 32.2% used medication; and 14.1% used more than one treatment. Social support was reported to have been received by 24.1%. More nicotine-dependent smokers were more likely to use medications (OR=3.58; 95% CI=3.04-4.20). At the time of the survey, 19.3% of attempters were abstinent > or =4 weeks. Smokers who sought treatment were less likely to be abstinent (OR=0.75; 95% CI=0.67-0.84), and those who sought multiple treatments were even less likely to be abstinent.
CONCLUSIONS: Many U.S. smokers make quit attempts, but most do not use behavioral or pharmacologic treatments. More nicotine-dependent smokers were more likely to seek treatment. Smokers who sought treatment were less likely to report abstinence, probably due to biased self-selection and recall. Retrospective survey data are not well-suited to assess the effectiveness of treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18201639     DOI: 10.1016/j.amepre.2007.09.033

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  182 in total

1.  Definition of a quit attempt: a replication test.

Authors:  John R Hughes; Peter W Callas
Journal:  Nicotine Tob Res       Date:  2010-10-05       Impact factor: 4.244

2.  The effect of removing cost as a barrier to treatment initiation with outpatient tobacco dependence clinics among emergency department patients.

Authors:  Deepak K Ozhathil; Beau Abar; Brigitte M Baumann; Carlos A Camargo; Douglas Ziedonis; Edwin D Boudreaux
Journal:  Acad Emerg Med       Date:  2011-04-22       Impact factor: 3.451

3.  Pharmacists' perceptions of participation in a community pharmacy-based nicotine replacement therapy distribution program.

Authors:  Matthew A Hoch; Karen Suchanek Hudmon; Linh Lee; Rebecca Cupp; Linda Aragon; Rachel A Tyree; Robin L Corelli
Journal:  J Community Health       Date:  2012-08

4.  Questions about quitting (Q2): design and methods of a Multiphase Optimization Strategy (MOST) randomized screening experiment for an online, motivational smoking cessation intervention.

Authors:  J B McClure; H Derry; K R Riggs; E W Westbrook; J St John; S M Shortreed; A Bogart; L C An
Journal:  Contemp Clin Trials       Date:  2012-07-04       Impact factor: 2.226

5.  Boosting population quits through evidence-based cessation treatment and policy.

Authors:  David B Abrams; Amanda L Graham; David T Levy; Patricia L Mabry; C Tracy Orleans
Journal:  Am J Prev Med       Date:  2010-03       Impact factor: 5.043

6.  Motivating the unmotivated for health behavior change: a randomized trial of cessation induction for smokers.

Authors:  Matthew J Carpenter; Anthony J Alberg; Kevin M Gray; Michael E Saladin
Journal:  Clin Trials       Date:  2010-03-25       Impact factor: 2.486

Review 7.  Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependence.

Authors:  Terril L Verplaetse; Andrea H Weinberger; Philip H Smith; Kelly P Cosgrove; Yann S Mineur; Marina R Picciotto; Carolyn M Mazure; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2015-03-11       Impact factor: 4.244

Review 8.  Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation.

Authors:  Andrea H Weinberger; Philip H Smith; Sharon S Allen; Kelly P Cosgrove; Michael E Saladin; Kevin M Gray; Carolyn M Mazure; Cora Lee Wetherington; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

9.  Clinician advice to quit smoking among seniors.

Authors:  William G Shadel; Marc N Elliott; Ann C Haas; Amelia M Haviland; Nate Orr; Melissa M Farmer; Sai Ma; Robert Weech-Maldonado; Donna O Farley; Paul D Cleary
Journal:  Prev Med       Date:  2014-12-04       Impact factor: 4.018

10.  Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics.

Authors:  Stevens S Smith; Danielle E McCarthy; Sandra J Japuntich; Bruce Christiansen; Megan E Piper; Douglas E Jorenby; David L Fraser; Michael C Fiore; Timothy B Baker; Thomas C Jackson
Journal:  Arch Intern Med       Date:  2009-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.